byiShook Opinion
Aug 12, 2024 - 12:25
Ascendis Pharma stock zoomed higher Monday — closing in on a breakout — after the FDA signed off on its embattled thyroid disease drug. The post Ascendis Pharma Zips Higher After FDA Approves Embattled Thyroid Drug appeared first on Investor's Business Daily.
Ascendis Pharma stock zoomed higher Monday â closing in on a breakout â after the FDA signed off on its embattled thyroid disease drug.
The post Ascendis Pharma Zips Higher After FDA Approves Embattled Thyroid Drug appeared first on Investor's Business Daily.